17 related articles for article (PubMed ID: 3018158)
1. Optimization using response surface methodology of phospholipase CÂ production from
Abdelkader I; Ben Mabrouk S; Hadrich B; Refai M; Fendri A; Sayari A
Prep Biochem Biotechnol; 2023 Nov; 53(10):1165-1175. PubMed ID: 36794326
[TBL] [Abstract][Full Text] [Related]
2. Attenuation of enkephalin activity in neuroblastoma X glioma NG108-15 hybrid cells by phospholipases.
Law PY; Griffin MT; Koehler JE; Loh HH
J Neurochem; 1983 Jan; 40(1):267-75. PubMed ID: 6294248
[TBL] [Abstract][Full Text] [Related]
3. Involvement of both inhibitory and stimulatory guanine nucleotide binding proteins in the expression of chronic opiate regulation of adenylate cyclase activity in NG108-15 cells.
Griffin MT; Law PY; Loh HH
J Neurochem; 1985 Nov; 45(5):1585-9. PubMed ID: 3930663
[TBL] [Abstract][Full Text] [Related]
4. Modulation of adenylate cyclase activity by a cytosolic factor following chronic opiate exposure in neuroblastoma x glioma NG108-15 hybrid cells.
Griffin MT; Law PY; Loh HH
Life Sci; 1983; 33 Suppl 1():365-8. PubMed ID: 6664218
[TBL] [Abstract][Full Text] [Related]
5. Opiate-dependent modulation of adenylate cyclase.
Sharma SK; Klee WA; Nirenberg M
Proc Natl Acad Sci U S A; 1977 Aug; 74(8):3365-9. PubMed ID: 269396
[TBL] [Abstract][Full Text] [Related]
6. The adenylate cyclase rebound response to naloxone in the NG108-15 cells. Effects of etorphine and other opiates.
Musacchio JM; Greenspan DL
Neuropharmacology; 1986 Aug; 25(8):833-7. PubMed ID: 3022177
[TBL] [Abstract][Full Text] [Related]
7. Effect of phospholipases on chronic opiate action in neuroblastoma X glioma NG108-15 hybrid cells.
Griffin MT; Law PY; Loh HH
J Neurochem; 1986 Oct; 47(4):1098-105. PubMed ID: 3018158
[TBL] [Abstract][Full Text] [Related]
8. Signal transduction mechanisms in mesenchymal cells.
McAllister BS; Walters JD; Olson MS
Crit Rev Oral Biol Med; 1994; 5(3-4):291-310. PubMed ID: 7703325
[TBL] [Abstract][Full Text] [Related]
9.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
